BioWorld - Friday, January 9, 2026

BioWorld Science

Sep. 15, 2021

View Archived Issues

Preclinical data presented for HIF-1 inhibitor LW-1564

Read More

EPRS inhibitor DWN-12088 shows antifibrotic effects in vitro and in vivo

Read More

Mitochondrial-encoded MOTS-c as novel therapeutic target in autoimmune diabetes

Read More

Bahcesehir Universitesi presents new Hdm2 inhibitors

Read More

CD39+ plasmablasts and adenosine identified as drivers of sepsis-induced long-term immunosuppression

Read More

JUN identified as a crucial regulator of pathological skin scarring via CD36

Read More

ZDWX-25, GSK-3beta/DYRK1A dual inhibitor with promising activity in models of AD

Read More

A subset of EGFR-mutant, MET-amplified lung cancers relies only on MET activation for survival

Read More

AZD-0095, selective MCT4 inhibitor with excellent potency in cancer models

Read More

Latrophilin-3 induces urothelial tumorigenesis and is a therapeutic target

Read More

Targeting late inflammation via complement system ameliorates TBI-induced epilepsy

Read More

Mindset Pharma shows MSP-1014 is comparable to psilocybin in drug discrimination assay

Read More

eIF4A3 identified as possible therapeutic target for cancer

Read More

U.S. researchers patent new compounds for malaria

Read More

Theseus Pharmaceuticals divulges EGFR mutant inhibitors

Read More

Vipergen and PhoreMost enter into multitarget drug discovery agreement

Read More

D-dimer predicts reduced DLCO in COVID-19-associated pneumonia

Read More